153 related articles for article (PubMed ID: 32316814)
1. Eslicarbazepine in patients with brain tumor-related epilepsy: a single-center experience.
Zoccarato M; Basile AM; Padovan M; Caccese M; Zagonel V; Lombardi G
Int J Neurosci; 2021 Sep; 131(9):879-884. PubMed ID: 32316814
[TBL] [Abstract][Full Text] [Related]
2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
3. Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.
Sperling MR; Abou-Khalil B; Harvey J; Rogin JB; Biraben A; Galimberti CA; Kowacs PA; Hong SB; Cheng H; Blum D; Nunes T; Soares-da-Silva P;
Epilepsia; 2015 Feb; 56(2):244-53. PubMed ID: 25528898
[TBL] [Abstract][Full Text] [Related]
4. The ROME (Retrospective Observational Multicenter study on Eslicarbazepine) study: Efficacy and behavioural effects of Eslicarbazepine acetate as adjunctive therapy for adults with partial onset seizures in real life.
Assenza G; Mecarelli O; Lanzone J; Assenza F; Tombini M; Di Lazzaro V; Pulitano P
Seizure; 2018 May; 58():35-40. PubMed ID: 29649684
[TBL] [Abstract][Full Text] [Related]
5. [Eslicarbazepine acetate in clinical practice. Efficacy and safety results].
Serrano-Castro PJ; Payán-Ortiz M; Cimadevilla JM; Quiroga-Subirana P; Fernández-Pérez J
Rev Neurol; 2013 Mar; 56(6):309-14. PubMed ID: 23483464
[TBL] [Abstract][Full Text] [Related]
6. Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.
Elger C; Koepp M; Trinka E; Villanueva V; Chaves J; Ben-Menachen E; Kowacs PA; Gil-Nagel A; Moreira J; Gama H; Rocha JF; Soares-da-Silva P
CNS Neurosci Ther; 2017 Dec; 23(12):961-972. PubMed ID: 29030894
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
Chung S; Sinha SR; Shah A; Stern JM; Cheng H; Jung J; Grinnell T; Blum D
Epilepsy Res; 2019 Jul; 153():59-65. PubMed ID: 30999260
[TBL] [Abstract][Full Text] [Related]
8. Effects of adjunctive eslicarbazepine acetate on neurocognitive functioning in children with refractory focal-onset seizures.
Jóźwiak S; Veggiotti P; Moreira J; Gama H; Rocha F; Soares-da-Silva P
Epilepsy Behav; 2018 Apr; 81():1-11. PubMed ID: 29454255
[TBL] [Abstract][Full Text] [Related]
9. Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli.
Sales F; Chaves J; McMurray R; Loureiro R; Fernandes H; Villanueva V
Acta Neurol Scand; 2020 Dec; 142(6):563-573. PubMed ID: 32691850
[TBL] [Abstract][Full Text] [Related]
10. Two-year follow-up with eslicarbazepine acetate: a consecutive, retrospective, observational study.
Correia FD; Freitas J; Magalhães R; Lopes J; Ramalheira J; Lopes-Lima J; Chaves J
Epilepsy Res; 2014 Oct; 108(8):1399-405. PubMed ID: 25060997
[TBL] [Abstract][Full Text] [Related]
11. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy.
Villanueva V; Bermejo P; Montoya J; Massot-Tarrús A; Galiano ML; Toledo M; Rodriguez-Uranga JJ; Bertol V; Mauri JÁ; Poza JJ; Bonet M; Castro-Vilanova MD; Ruiz-Giménez J; López-González FJ; Rodríguez-Osorio X; Tortosa-Conesa D; Ojeda J; Giner P; Garcés M; Alvarez BM; Quiroga-Subirana P; Esteve P; Baiges JJ; Hampel K
Epilepsy Behav; 2019 Aug; 97():51-59. PubMed ID: 31181429
[TBL] [Abstract][Full Text] [Related]
12. Associations between seizure severity change and patient characteristics, changes in seizure frequency, and health-related quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate: Post hoc analyses of clinical trial results.
Cramer JA; Colman S; Anastassopoulos KP; Grinnell T; Mehta D; Williams GR
Epilepsy Behav; 2020 Nov; 112():107312. PubMed ID: 32801102
[TBL] [Abstract][Full Text] [Related]
13. Levels of anger in epilepsy patients treated with eslicarbazepine acetate.
Toledo M; Mazuela G; Mauri JA; Rodriguez-Osorio X; Gómez-Eguilaz M; Castro-Vilanova D; Rodriguez-Uranga J; Santamarina E
Acta Neurol Scand; 2019 Jul; 140(1):48-55. PubMed ID: 30953593
[TBL] [Abstract][Full Text] [Related]
14. Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapy.
Holtkamp M; McMurray R; Bagul M; Sousa R; Kockelmann E
Acta Neurol Scand; 2016 Jul; 134(1):76-82. PubMed ID: 26915469
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P;
Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit.
Giráldez BG; Garamendi-Ruiz I; Zurita J; García A; Querol R; Campos D; Cabeza-Alvarez C; Serrano P; López-González FJ; Molins A; Serratosa JM
Acta Neurol Scand; 2019 Dec; 140(6):422-428. PubMed ID: 31498422
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.
Perucca E; Elger C; Halász P; Falcão A; Almeida L; Soares-da-Silva P
Epilepsy Res; 2011 Sep; 96(1-2):132-9. PubMed ID: 21680153
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study.
Toledano R; Jovel CE; Jiménez-Huete A; Bayarri PG; Campos D; Gomariz EL; Giráldez BG; García-Morales I; Falip M; Agredano PM; Palao S; Prior MJAA; Pascual MRQ; Navacerrada FJ; González FJL; Ojeda J; Sáez AA; Bermejo PE; Gil-Nagel A
Epilepsy Behav; 2017 Aug; 73():173-179. PubMed ID: 28641170
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome.
Svendsen T; Brodtkorb E; Reimers A; Molden E; Sætre E; Johannessen SI; Johannessen Landmark C
Epilepsy Res; 2017 Jan; 129():125-131. PubMed ID: 28043062
[TBL] [Abstract][Full Text] [Related]
20. Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies.
Sperling MR; French J; Jacobson MP; Pazdera L; Gough M; Cheng H; Grinnell T; Blum D;
Neurology; 2016 Mar; 86(12):1095-102. PubMed ID: 26911639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
